HPV Vaccination Rate for Junior High Boys in Taiwan Exceeds 80% After One Year

Taiwan's Health Promotion Administration announced that the HPV vaccination rate for junior high school boys has reached 81.6% in its first year. Girls' vaccination rates have also stabilized at 90%, meeting WHO goals. The agency emphasizes that HPV poses cancer risks to all genders and encourages early vaccination.
healthNQ 46/100出典:PR Times

📋 Article Processing Timeline

  • 📰 Published: June 1, 2026 at 15:44
  • 🔍 Collected: June 1, 2026 at 15:55 (11 min after Published)
  • 🤖 AI Analyzed: June 1, 2026 at 15:58 (2 min after Collected)
Central News Agency, Taipei, June 1. The public-funded HPV vaccination program for junior high school boys has reached its one-year milestone, with the first-dose coverage exceeding 80%. The vaccination rate for junior high school girls has also stabilized at 90%. The Health Promotion Administration (HPA) reminds the public that adolescence is the golden period for vaccination and urges early establishment of cancer prevention barriers. HPV threats are gender-neutral. Accumulated medical evidence confirms that HPV is linked to various cancers, and both men and women face risks upon infection. The World Health Organization (WHO) recommends vaccination before exposure to HPV for optimal protection. Since last September, the HPA has included junior high boys in the public-funded program, with the first-dose rate reaching 81.6%. Girls have been eligible since 2018, currently meeting the WHO's 2030 goal of 90% for cervical cancer elimination. HPA section chief Hsieh Pei-chun stated that the performance is excellent and expects further growth. As of mid-May, the girls' first-dose rate reached 92.2%. The HPA has allocated approximately NT$550 million for 2026. HPV vaccines are not just 'cervical cancer vaccines' but prevent HPV-related cancers in both genders, including oropharyngeal and anal cancers.

FAQ

Who is eligible for free HPV vaccines in Taiwan?

Currently, junior high school students of both genders.